Biotech | October 11, 2022
Panacea Biotec bags US $127.30 mn for supply of Pentavalent Vaccine
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
The OAI classification implies that the USFDA expects further corrective actions and may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved
He has done his Masters in Pharmacy (M. Pharm) and Post Graduate Diploma in Personnel Management & Industrial Relations
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
It posted net (loss) of Rs.(34.13) crores for the period ended June 30, 2020.
The said batches have successfully passed all the checks for quality parameters both at the Gamaleya Center in Russia and at the Central Drug Laboratory, Kasauli in India
The company reported total income of Rs.634.79 crores during the 12 months period ended March 31, 2021
Subscribe To Our Newsletter & Stay Updated
